HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel P Stiehl Selected Research

Myopia 5

10/20212-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel P Stiehl Research Topics

Disease

22Hypoxia (Hypoxemia)
01/2014 - 02/2002
8Neoplasms (Cancer)
01/2014 - 04/2003
3Breast Neoplasms (Breast Cancer)
01/2014 - 11/2011
2Hepatocellular Carcinoma (Hepatoma)
11/2011 - 02/2002
1Retinopathy of Prematurity (Retrolental Fibroplasia)
10/2021
1Myopia 5
10/2021
1Myopia
10/2021
1Birth Weight (Birth Weights)
10/2021
1Autoimmune Diseases (Autoimmune Disease)
11/2016
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2016
1Infections
11/2016
1Tuberculosis (Tuberculoses)
11/2016
1Polycythemia (Erythrocytosis)
10/2013
1primary familial and congenital Polycythemia
10/2013
1Renal Cell Carcinoma (Grawitz Tumor)
06/2012
1Carcinoma (Carcinomatosis)
11/2011
1Ascorbic Acid Deficiency (Vitamin C Deficiency)
05/2011
1Scurvy (Scorbutus)
05/2011
1Inflammation (Inflammations)
06/2005

Drug/Important Bio-Agent (IBA)

16Oxygen (Dioxygen)IBA
01/2014 - 04/2003
10Proteins (Proteins, Gene)FDA Link
01/2014 - 06/2005
7Transcription Factors (Transcription Factor)IBA
05/2011 - 01/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2005
4Messenger RNA (mRNA)IBA
01/2014 - 01/2005
3DNA (Deoxyribonucleic Acid)IBA
04/2013 - 02/2002
3EnzymesIBA
12/2011 - 08/2006
2ErythropoietinFDA Link
10/2013 - 05/2011
2Carbonic Anhydrase IXIBA
12/2011 - 12/2005
2Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
08/2006 - 05/2005
2Interleukin-1beta (Interleukin 1 beta)IBA
01/2005 - 02/2002
1Ranibizumab (Lucentis)FDA Link
10/2021
1Interleukin-17 (Interleukin 17)IBA
11/2016
1Neutralizing AntibodiesIBA
11/2016
1AntibodiesIBA
11/2016
1Phenobarbital (Luminal)FDA Link
01/2014
1Histones (Histone)IBA
04/2013
1Glycoproteins (Glycoprotein)IBA
06/2012
1Biomarkers (Surrogate Marker)IBA
06/2012
1Membrane Proteins (Integral Membrane Proteins)IBA
06/2012
1Biological ProductsIBA
06/2012
1MyoglobinIBA
12/2011
1Codon (Codons)IBA
12/2011
1GlobinsIBA
11/2011
1Lactate Dehydrogenase 5IBA
11/2011
1Pyruvate KinaseIBA
06/2011
1CollagenIBA
05/2011
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
05/2011
1fluoromisonidazoleIBA
08/2009
1LuciferasesIBA
08/2009
1oxalylglycineIBA
11/2007
1Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
05/2007
1geldanamycinIBA
12/2005
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2005
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2005
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2005
1Heme Oxygenase-1IBA
06/2005
1ElementsIBA
05/2005
1Glucose (Dextrose)FDA LinkGeneric
04/2003
1Mitogen-Activated Protein KinasesIBA
04/2003
1U 0126 (UO 126)IBA
02/2002
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
02/2002
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
02/2002
1Interleukin-1 (Interleukin 1)IBA
02/2002
1Insulin (Novolin)FDA Link
02/2002
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2002
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2002
1Peptides (Polypeptides)IBA
02/2002

Therapy/Procedure

5Therapeutics
11/2016 - 12/2005
1Intravitreal Injections
10/2021
1Laser Therapy (Surgery, Laser)
10/2021
1Drug Therapy (Chemotherapy)
04/2013